Scientists are making the case that a vaccine against rhinoviruses, the predominant cause of the common cold, is achievable.
The quest for a vaccine against rhinoviruses may have seemed quixotic, because there are more than 100 varieties circulating around the world. Even so, the immune system can handle the challenge, researchers from Emory University School of Medicine and Children’s Healthcare of Atlanta say.
Vaccines that combine dozens of varieties of rhinovirus at once are effective in stimulating antiviral antibodies in mice and monkeys, the researchers report in Nature Communications. The paper was also posted on Biorxiv before publication.
“We think that creating a vaccine for the common cold can be reduced to technical challenges related to manufacturing,” says Martin Moore, PhD, associate professor of pediatrics at Emory University School of Medicine.
Rhinoviruses are the most common cause of the common cold; other viruses such as respiratory syncytial virus, parainfluenza virus and adenoviruses can cause them too. Rhinoviruses also exacerbate asthma attacks. Although they come in many varieties, rhinoviruses do not drift to the same degree that influenza viruses do, Moore says.
Researchers showed in the 1960s that it was possible to vaccinate people against one variety of rhinovirus and prevent them from getting sick when challenged with samples of the same virus. The trouble was the sheer diversity of rhinoviruses – or that’s how it appeared at the time.
“It’s surprising that nobody tried such a simple solution over the last 50 years. We just took 50 types of rhinovirus and mixed them together into our vaccine, and made sure we had enough of each one,” Moore says. “If we make a vaccine with 50 or 100 variants, it’s the same amount of total protein in a single dose of vaccine. The variants are like a bunch of slightly different Christmas ornaments, not really like 50 totally different vaccines mixed.”
A mixture of 25 types of inactivated rhinovirus can stimulate neutralizing antibodies against all 25 in mice, and a mixture of 50 types can do the same thing in rhesus macaques. In this paper, antibodies generated in response to the vaccine were tested for their ability to prevent the virus from infecting human cells in culture. However, the vaccines were not tested for their ability to stop animals from getting sick.
“There are no good animal models of rhinovirus replication,” Moore says. “The next step would be human challenge models with volunteers, which are feasible because the virus is not very pathogenic.”
Emory has optioned the vaccine technology to a startup company, Meissa Vaccines, Inc., which is pursuing a product development plan with support from the National Institute of Allergy and Infectious Diseases’ vaccine manufacturing services.
Learn more: Vaccine vs many common cold viruses achievable
The Latest on: Vaccine against rhinoviruses
[google_news title=”” keyword=”vaccine against rhinoviruses” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Vaccine against rhinoviruses
- Our new vaccine could protect against coronaviruses that haven’t even emerged yet – new studyon May 7, 2024 at 7:53 am
The rapid development of vaccines that protect against COVID was a remarkable scientific achievement that saved millions of lives. The vaccines have demonstrated substantial success in reducing death ...
- New vaccine technology provides protection against broad range of coronaviruses in miceon May 6, 2024 at 1:19 pm
Researchers have developed a new vaccine technology that has been shown in mice to provide protection against a broad range of coronaviruses with potential for future disease outbreaks - including ...
- Research aims to develop vaccine against future COVID viruseson May 6, 2024 at 7:48 am
Scientists are busy working on a vaccine that might fight strains of the COVID virus SARS-CoV-2 that haven't even emerged yet.
- Durable lymph-node expansion improves vaccine responses against tumorson May 6, 2024 at 6:59 am
Each one of us has around 600 lymph nodes (LNs) – small, bean-shaped organs that house various types of blood cells and filter lymph fluid – scattered throughout our bodies.
- New vaccine effective against coronaviruses that haven’t even emerged yeton May 6, 2024 at 2:01 am
Rory Hills, a graduate researcher in the University of Cambridge’s Department of Pharmacology, wants to be ready with a vaccine that will protect us against the next coronavirus pandemic before the ...
- New mRNA Vaccines in Development for Cancer and Infectionson May 2, 2024 at 2:22 am
Prelog also discussed personalized vaccines for cancer immunotherapy. Personalized mRNA vaccines are tailored to the patient's genetic characteristics and antigens. They could be used in cancer ...
- COVID-19 Vaccine Trackeron April 24, 2024 at 8:39 am
Most health groups previously took cautious stances, neither recommending nor advising against vaccination for those who are pregnant. That's because initial COVID-19 vaccine trials enrolled non ...
- A vaccine to fight antibiotic resistanceon April 24, 2024 at 2:01 am
An artistic recreation of MRSA. Michigan State University researcher Xuefei Huang is developing new vaccine science in the fight against antibiotic resistance. Driven by the overuse of ...
- Vaccine fighting all viruses finally createdon April 22, 2024 at 4:59 pm
UC Riverside researchers have created a novel vaccine employing RNA, that is safe for use by immunocompromised individuals and effective against all strains of the virus. Each year, scientists ...
via Bing News